Department of Immunology, MS Center ErasMS, Erasmus MC, University Medical Center Rotterdam, 3015 CN, Rotterdam, The Netherlands.
Neuroimmunology Research Group, Netherlands Institute for Neuroscience, 1105 BA, Amsterdam, The Netherlands.
EBioMedicine. 2023 Mar;89:104465. doi: 10.1016/j.ebiom.2023.104465. Epub 2023 Feb 14.
Although distinct brain-homing B cells have been identified in multiple sclerosis (MS), it is unknown how these further evolve to contribute to local pathology. We explored B-cell maturation in the central nervous system (CNS) of MS patients and determined their association with immunoglobulin (Ig) production, T-cell presence, and lesion formation.
Ex vivo flow cytometry was performed on post-mortem blood, cerebrospinal fluid (CSF), meninges and white matter from 28 MS and 10 control brain donors to characterize B cells and antibody-secreting cells (ASCs). MS brain tissue sections were analysed with immunostainings and microarrays. IgG index and CSF oligoclonal bands were measured with nephelometry, isoelectric focusing, and immunoblotting. Blood-derived B cells were cocultured under T follicular helper-like conditions to evaluate their ASC-differentiating capacity in vitro.
ASC versus B-cell ratios were increased in post-mortem CNS compartments of MS but not control donors. Local presence of ASCs associated with a mature CD45 phenotype, focal MS lesional activity, lesional Ig gene expression, and CSF IgG levels as well as clonality. In vitro B-cell maturation into ASCs did not differ between MS and control donors. Notably, lesional CD4 memory T cells positively correlated with ASC presence, reflected by local interplay with T cells.
These findings provide evidence that local B cells at least in late-stage MS preferentially mature into ASCs, which are largely responsible for intrathecal and local Ig production. This is especially seen in active MS white matter lesions and likely depends on the interaction with CD4 memory T cells.
Stichting MS Research (19-1057 MS; 20-490f MS), National MS Fonds (OZ2018-003).
尽管多发性硬化症(MS)中已经鉴定出具有明显归巢到脑部特征的 B 细胞,但尚不清楚这些 B 细胞如何进一步进化以促进局部病理。我们研究了 MS 患者中枢神经系统(CNS)中 B 细胞的成熟过程,并确定了其与免疫球蛋白(Ig)产生、T 细胞存在和病变形成的关系。
对 28 名 MS 患者和 10 名对照脑供体死后血液、脑脊液(CSF)、脑膜和白质进行离体流式细胞术,以表征 B 细胞和分泌抗体的细胞(ASC)。对 MS 脑组织切片进行免疫染色和微阵列分析。用散射比浊法、等电聚焦和免疫印迹法测量 IgG 指数和 CSF 寡克隆带。将血液来源的 B 细胞在滤泡辅助 T 细胞样条件下共培养,以评估其在体外的 ASC 分化能力。
MS 死后 CNS 隔室中的 ASC 与 B 细胞比值升高,但对照供体没有升高。局部 ASC 存在与成熟的 CD45 表型、局灶性 MS 病变活性、病变 Ig 基因表达、CSF IgG 水平以及克隆性相关。MS 和对照供体之间的 B 细胞体外成熟为 ASC 没有差异。值得注意的是,病变 CD4 记忆 T 细胞与 ASC 存在呈正相关,反映了与 T 细胞的局部相互作用。
这些发现提供了证据,表明至少在晚期 MS 中,局部 B 细胞优先成熟为 ASC,这主要负责鞘内和局部 Ig 产生。这在活动性 MS 白质病变中尤为明显,可能依赖于与 CD4 记忆 T 细胞的相互作用。
多发性硬化症研究基金会(19-1057 MS;20-490f MS),国家多发性硬化症基金(OZ2018-003)。